Ciclopirox Olamine (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Ciclopirox Olamine drug offered from Glenmark Pharmaceuticals Inc., USA. This Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Ciclopirox Olamine |
| SUBSTANCE NAME: | CICLOPIROX OLAMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-11-13 |
| END MARKETING DATE: | 0000-00-00 |
Ciclopirox Olamine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ciclopirox Olamine from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.7(mg/g) |
| START MARKETING DATE: | 2009-11-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-297_57a109a9-734f-4b19-ba06-72f300f52863 |
| PRODUCT NDC: | 68462-297 |
| APPLICATION NUMBER: | ANDA090273 |
Other CICLOPIROX OLAMINE Pharmaceutical Manufacturers / Labelers:
